Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2023 Earnings Call Transcript August 11, 2023
Iterum Therapeutics plc misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.8.
Operator: Good morning, and welcome to the Iterum Therapeutics Second Quarter 2023 Financial Results Call. My name is Carla, and I will be the operator of today’s call. [Operator Instructions] I would now like to pass the conference over to our host, Louise Barrett to begin. Louise, please go ahead...
